4.39
Lantern Pharma Inc (LTRN) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
-
|
- | - | - | - |
|
19.03%
4.774
|
5.8964 | 5.1796 | 5.4085 | 5.732 |
Depreciation and Amortization |
0.00%
0.00457
|
0.00457 | - | - | - |
Operating Income/Loss |
19.03%
-4.774
|
-5.8964 | -5.1796 | -5.4085 | -5.732 |
Income/Loss From Continuing Operations Before Tax |
22.78%
-4.5368
|
-5.8752 | -4.5057 | -4.9595 | -5.4408 |
Income/Loss From Continuing Operations After Tax |
22.78%
-4.5368
|
-5.8752 | -4.5057 | -4.9595 | -5.4408 |
|
22.78%
-4.5368
|
-5.8752 | -4.5057 | -4.9595 | -5.4408 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
147.56K%
10.78
|
0.0073 | 10.76 | 10.76 | 10.74 |
Diluted Average Shares |
147.56K%
10.78
|
0.0073 | 10.76 | 10.76 | 10.74 |
Basic Earnings Per Share |
22.22%
-0.42
|
-0.54 | -0.42 | -0.46 | -0.51 |
Diluted Earnings Per Share |
22.22%
-0.42
|
-0.54 | -0.42 | -0.46 | -0.51 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):